Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...

Cotiviti, a healthcare data company backed by KKR, is reportedly on the brink of finalizing a deal to acquire its smaller ...

In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on KKR & Co (KKR – Research Report), with a price ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

UnitedHealth (NYSE:UNH) has contacted the US Securities and Exchange Commission about its issues with hedge fund investor ...

Plus, the food conglomerate owner of Krispy Kreme buys an insurance company and a distressed-debt battle in Japan ...

Ratos AB Series B-2.41% kr11.59B ...